To continue, please confirm that you are a healthcare professional below
This condition prevents the stomach from emptying properly, leading to chronic nausea, vomiting, abdominal pain, and early satiety
This slowing contributes to the appetite suppression that drives weight loss and the postprandial glucose-lowering effect, and it also drives most of the gastrointestinal side effect profile.[1],[2] A 2025 review in the Journal of Clinical Endocrinology & Metabolism summarizes the published evidence: GLP-1 receptor agonists impact gastric, intestinal, and gallbladder motility simultaneously, with effects on gastric fundus relaxation, antral contractility inhibition, increased pyloric tone, and reduced small intestinal motility.[3] The path from this mechanism to constipation is straightforward
Find articles by Doyle, M
Weight loss reports vary widely